Cronos Group Inc.
Cronos Group Inc. is a cannabinoid company that develops, brands, manufactures, and distributes cannabis products for adult-use and medical markets. Its portfolio includes Spinach®, PEACE NATURALS®, LIT™, and Lord Jones®, and it operates through licensed production and distribution assets in Canada and Israel.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueFinished cannabis products sold under Cronos-owned consumer brands across adult-use and medical channels.
Sales to provincial cannabis control authorities and private-sector retailers in Canada.
Licensed cultivation, distribution, and pharmacy-based medical cannabis products in Israel.
Third-party sourcing, contract manufacturing, and processing services supporting product availability.
Products
Reported · share of revenue- Cannabis Flower74.0 %
- Cannabis Extracts25.7 %
- Other0.3 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Cronos sells primarily to government-controlled cannabis authorities, licensed retailers, and medical cannabis channels rather than direct mass-market consumers. In Canada, the main buyers are provincial cannabis control authorities and, in some provinces, private-sector retailers; in Israel, the company serves the regulated medical cannabis market through licensed distribution and pharmacy channels.
Buy wholesale cannabis products for provincial retail distribution and are the largest revenue source.
Purchase cannabis products for resale in provinces where private distribution is permitted.
Buys branded medical cannabis products through licensed cultivation, distribution, and pharmacy channels.
Buy dried flower and other cannabis products for export or resale in select international markets.
Strategy
Cronos is focused on building branded cannabis franchises, expanding distribution, and improving supply chain efficiency while monetizing intellectual property. The company is also increasing production capacity, including the Cronos GrowCo expansion, to support domestic Canadian demand and international growth.
Branded products can improve differentiation in a crowded cannabis market.
Broader channel access reduces reliance on any single country or buyer group.
More reliable production and lower unit costs support margins and service levels.
Proprietary product development can create longer-term competitive advantages.
Geography
Q1/2026Cronos is operationally concentrated in Canada and Israel, with principal facilities near Stayner, Ontario and licensed operations in Israel. The company also supplies select international markets, but its reported business is still anchored in regulated North American and Israeli cannabis regimes, which creates exposure to local licensing, import/export, and pricing rules.
Share of the revenue the company reports by geography.
Risks
Cronos faces regulatory, supply-chain, and market-structure risk because cannabis remains highly controlled and country-specific. The business also depends on a small number of large buyers, third-party suppliers, and agricultural production assets, which can create volatility in volumes, pricing, and margins.
- Supply chain and agricultural disruptionImpact: HighLikelihood: High
Production depends on cultivation, third-party suppliers, and manufacturing partners.
Exposure - Regulatory and licensing dependenceImpact: HighLikelihood: Medium
Cannabis sales require country-specific licenses and compliance with changing laws.
Exposure - Customer concentrationImpact: High
A few provincial authorities account for a large share of revenue, limiting bargaining power.
Exposure - Competitive pressure and illicit marketImpact: MediumLikelihood: High
Oversupply and illegal cannabis can reduce pricing and market share in adult-use channels.
Exposure: Canadian adult-use market
- Impairment of goodwill and intangiblesImpact: MediumLikelihood: High
Brand and reporting-unit values depend on future cash flow assumptions and market conditions.
Exposure: Lord Jones® and other acquired/intangible assets
Accounting
Judgemental itemsWholesale cannabis sales and excise taxes can affect reported net revenue and timing.
Impact: Affects quarterly comparability and gross margin presentation
Brand and reporting-unit values depend on future cash flow forecasts and market assumptions.
Impact: Can create large non-cash charges if expectations weaken
Cultivation and processing businesses face obsolescence, yield, and cost-allocation judgments.
Impact: Can materially affect cost of sales and gross profit
Valuation of acquired assets and reporting units uses discount rates, growth rates, and royalty assumptions.
Impact: Influences impairment testing and acquisition accounting
Similar listed companies
Publicly listed companies with a comparable business focus.
Kronos Worldwide Inc
KRO · Industrial Inorganic Chemicals
Kronos Worldwide makes titanium dioxide (TiO2) pigments, a white inorganic material used to add brightness, opacity and durability to coatings, plastics, paper and other products.
Target Group Inc.
CBDY · Medicinal Chemicals & Botanical Products
Verano Holdings Corp.
VRNO · Agricultural Production-Crops
IM Cannabis Corp.
IMCC · Medicinal Chemicals & Botanical Products
CordovaCann Corp.
LVRLF · Services-Amusement & Recreation Services
Cannapharmarx, Inc.
CPMD · Pharmaceutical Preparations
Last updated: 24/09/2026